UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☐
Filed by a Party other than the Registrant ☒
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the
Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☒ | Soliciting Material under §240.14a-12 |
STAAR Surgical Company
(Name of Registrant as Specified In Its Charter)
Broadwood Partners, L.P.
Broadwood Capital, Inc.
Neal C. Bradsher
Richard T. LeBuhn
Natalie R. Capasso
Raymond A. Myers
Jason J. Martin
(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☐ | Fee paid previously with preliminary
materials |
| ☐ | Fee computed on table in exhibit
required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
On October 22, 2025, Broadwood Partners, L.P.,
collectively with its affiliates, and the other parties named therein filed with the U.S. Securities and Exchange Commission (the “SEC”)
an Amendment No. 39 to their Schedule 13D with respect to STAAR Surgical Company (the “Company”), a copy of which is attached
hereto as Exhibit 1 and incorporated herein by reference, and issued a press release, a copy of which is attached hereto as Exhibit 2 and incorporated herein by reference.
CERTAIN INFORMATION CONCERNING THE PARTICIPANTS
Special Meeting of Stockholders Scheduled for
October 23, 2025
Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”)
are participants in the solicitation of proxies from the stockholders of the Company in connection with the special meeting of stockholders
scheduled for October 23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special
Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”)
and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies from the Company’s
stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS
OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE SEC BECAUSE THEY CONTAIN
OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND ADDITIONAL INFORMATION RELATING
TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The Definitive Proxy Statement and
accompanying GREEN Proxy Card have been furnished to some or all of Company’s stockholders and will be, along with
other relevant documents, available at no charge on the SEC’s website at https://www.sec.gov/.
Special Meeting of Stockholders to Remove Members
of the Board
The Participants also intend to file a definitive
proxy statement and an accompanying GREEN Proxy Card with the SEC to be used to solicit proxies with respect to removing
members of the Board and any other proposals that may come before a future and yet to be called or otherwise scheduled special meeting
of stockholders (including any adjournments, postponements, reschedulings or continuations thereof, the “Stockholder Meeting”).
The Stockholder Meeting will be separate, distinct and unrelated to the Special Meeting, and the Participants believe that the Stockholder
Meeting will have no effect on the outcome of the Special Meeting. The Participants do not believe that there is any lawful reason that
would prevent or prohibit the Participants from calling the Stockholder Meeting, regardless of the outcome of the stockholder vote at
the Special Meeting, and do not make any representation related to whether the Company may contest, or otherwise challenge, the Participants’
ability to call the Stockholder Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS
OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE
THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE STOCKHOLDER MEETING AND ADDITIONAL INFORMATION
RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The definitive proxy statement
and an accompanying GREEN Proxy Card will be furnished to some or all of the Company’s stockholders and will be,
along with other relevant documents, available at no charge on the SEC’s website at https://www.sec.gov/.
Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on October 22, 2025 and is available here.
Exhibit 1
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13D
Under
the Securities Exchange Act of 1934
(Amendment No. 39)
STAAR
SURGICAL CO
(Name
of Issuer)
Common
Stock, par value $0.01 per share
(Title of Class of Securities)
852312305
(CUSIP Number)
Neal
C. Bradsher
c/o
Broadwood Capital, Inc., 156 West 56th Street, 3rd Floor,
New
York, NY, 10019
(212) 508-5735
(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)
10/21/2025
(Date
of Event Which Requires Filing of This Statement)
If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
1 |
Name of reporting person
Broadwood Partners, L.P. |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only |
|
4 |
Source of funds (See Instructions)
WC |
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
DELAWARE |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
0.00 |
|
|
8 |
Shared Voting Power
13,519,491.00 |
|
9 |
Sole Dispositive Power
0.00 |
|
10 |
Shared Dispositive Power
13,519,491.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
13,519,491.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
27.4 % |
|
14 |
Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
1 |
Name of reporting person
Broadwood Capital, Inc. |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only
|
|
4 |
Source of funds (See Instructions)
AF |
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
NEW YORK |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
0.00 |
|
|
8 |
Shared Voting Power
13,519,491.00 |
|
9 |
Sole Dispositive Power
0.00 |
|
10 |
Shared Dispositive Power
13,519,491.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
13,519,491.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
27.4 % |
|
14 |
Type of Reporting Person (See Instructions)
CO, IA |
SCHEDULE 13D
|
1 |
Name of reporting person
Neal C. Bradsher |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only
|
|
4 |
Source of funds (See Instructions)
AF, PF |
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
UNITED STATES |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
25,900.00 |
|
|
8 |
Shared Voting Power
13,519,491.00 |
|
9 |
Sole Dispositive Power
25,900.00 |
|
10 |
Shared Dispositive Power
13,519,491.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
13,545,391.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
27.4 % |
|
14 |
Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
1 |
Name of reporting person
Richard T. LeBuhn |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only |
|
4 |
Source of funds (See Instructions)
PF |
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
UNITED STATES |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
21,280.00 |
|
|
8 |
Shared Voting Power
6.00 |
|
9 |
Sole Dispositive Power
21,280.00 |
|
10 |
Shared Dispositive Power
6.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
21,286.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain
shares (See Instructions)
☒ |
|
13 |
Percent of class represented by amount in Row (11)
0.0 % |
|
14 |
Type of Reporting Person (See Instructions)
IN |
| Comment for Type of Reporting Person: |
|
Box 11 - Does not include 2,532 Shares over which
Mr. LeBuhn does not have direct or indirect beneficial ownership. Such shares are held in three separate irrevocable trusts for Mr. LeBuhn's
daughters in which Mr. LeBuhn has no voting or dispositive power and disclaims any beneficial ownership interest in such shares. |
SCHEDULE 13D
|
1 |
Name of reporting person
Natalie R. Capasso |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only |
|
4 |
Source of funds (See Instructions)
|
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
UNITED STATES |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
0.00 |
|
|
8 |
Shared Voting Power
0.00 |
|
9 |
Sole Dispositive Power
0.00 |
|
10 |
Shared Dispositive Power
0.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
0.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
0 % |
|
14 |
Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
1 |
Name of reporting person
Raymond A. Myers |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only |
|
4 |
Source of funds (See Instructions)
|
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
UNITED STATES |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
0.00 |
|
|
8 |
Shared Voting Power
0.00 |
|
9 |
Sole Dispositive Power
0.00 |
|
10 |
Shared Dispositive Power
0.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
0.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
0 % |
|
14 |
Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
1 |
Name of reporting person
Jason J. Martin |
|
2 |
Check the appropriate box if a member of a Group (See
Instructions)
☐ (a)
☒ (b) |
| 3 |
SEC use only |
|
4 |
Source of funds (See Instructions)
|
|
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐ |
|
6 |
Citizenship or place of organization
UNITED STATES |
|
Number of Shares
Beneficially Owned by Each Reporting Person With: |
7 |
Sole Voting Power
0.00 |
|
|
8 |
Shared Voting Power
0.00 |
|
9 |
Sole Dispositive Power
0.00 |
|
10 |
Shared Dispositive Power
0.00 |
|
11 |
Aggregate amount beneficially owned by each reporting
person
0.00 |
|
12 |
Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
☐ |
|
13 |
Percent of class represented by amount in Row (11)
0 % |
|
14 |
Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
| |
Item 1. | Security and Issuer |
| (a) | Title of Class of Securities: |
Common Stock, par value $0.01 per share
STAAR SURGICAL CO
| (c) | Address of Issuer's Principal Executive Offices: |
25510 Commercentre Drive, Lake Forest, CA 92630
| Item 1 Comment: | This Amendment No. 39 to the Schedule 13D ("Amendment No. 39"), amends and supplements the statement on Schedule 13D filed with the U.S. Securities
and Exchange Commission (the "SEC") on October 12, 2004, (the "Original Schedule 13D," as amended, the "Schedule
13D") with respect to shares of common stock, par value $0.01 per share (the "Shares") of STAAR Surgical Company (the
"Issuer"). Capitalized terms used but not otherwise defined in this Amendment No. 39 have the meanings set forth in the Schedule
13D. |
| Item 4. | Purpose of Transaction |
Item 4 is hereby amended and supplemented by the addition
of the following:
On October 21, 2025, the Reporting Persons notified
the Board of their intent to call a special meeting of stockholders for the purpose of removing several of the Issuer's directors, whose
identities have yet to be determined by the Reporting Persons, from the Board and cautioned the Board not to take any procedural or substantive
actions with respect to the Proposed Merger in advance of the stockholder vote at the Special Meeting scheduled for October 23, 2025 (such
notification to the Board, the "October 21 Correspondence"). As part of the October 21 Correspondence, the Reporting Persons
also referenced the ongoing contested solicitation in connection with the Reporting Persons' opposition to stockholder approval of the
Merger Agreement Proposal and the Compensation Proposal to be considered at the Special Meeting and shared with the Issuer certain views
from the Reporting Persons' proxy solicitor about the Special Meeting. As of the date hereof, the Issuer had not yet responded to the
October 21 Correspondence.
The special meeting to remove several of the Issuer's
directors will be separate, distinct and unrelated to the Special Meeting and the Reporting Persons believe that this potential special
meeting of stockholders will have no effect on the outcome of the Special Meeting. Regardless of the outcome of the stockholder vote on
the Merger Agreement Proposal and the Compensation Proposal at the Special Meeting, the Reporting Persons believe they are entitled to
call a special meeting to remove several of the Issuer's directors thereafter under the Issuer's governing documents and applicable state
law. The Reporting Persons' take no position on how, or if, the Issuer will contest, or otherwise challenge, the Reporting Persons' ability
to call a special meeting of stockholders to remove several directors.
The Reporting Persons may consider and/or make other
proposals (whether preliminary or final) with respect to meetings of stockholders. The Reporting Persons intend to communicate with the
Issuer's management and Board about, and may enter into negotiations and agreements with them regarding, the foregoing and to communicate
with other stockholders or third parties, including potential director and management candidates, regarding the Issuer. The Reporting
Persons may exchange information with any such persons pursuant to appropriate confidentiality or similar agreements.
The Reporting Persons intend to file a proxy statement
and accompanying proxy card with the SEC to be used to solicit proxies with respect to the removal of several of the Issuer's directors
and other proposals that may come before a future and yet to be called or otherwise scheduled special meeting of stockholders. Notwithstanding
such intent, the Reporting Persons may change their intentions with respect to any and all matters referred to in this Item 4.
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is true, complete and correct.
| |
Broadwood Partners, L.P. |
| |
|
| |
Signature: |
/s/ Neal C. Bradsher |
| |
Name/Title: |
Neal C. Bradsher, President of Broadwood Capital, Inc. |
| |
Date: |
10/22/2025 |
| |
Broadwood Capital, Inc. |
| |
|
|
| |
Signature: |
/s/ Neal C. Bradsher |
| |
Name/Title: |
Neal C. Bradsher, President |
| |
Date: |
10/22/2025 |
| |
Neal C. Bradsher |
| |
|
| |
Signature: |
/s/ Neal C. Bradsher |
| |
Name/Title: |
Neal C. Bradsher |
| |
Date: |
10/22/2025 |
| |
Richard T. LeBuhn |
| |
|
| |
Signature: |
/s/ Richard T. LeBuhn |
| |
Name/Title: |
Richard T. LeBuhn |
| |
Date: |
10/22/2025 |
| |
Natalie R. Capasso |
| |
|
| |
Signature: |
/s/ Natalie R. Capasso |
| |
Name/Title: |
Natalie R. Capasso |
| |
Date: |
10/22/2025 |
| |
Raymond A. Myers |
| |
|
| |
Signature: |
/s/ Raymond A. Myers |
| |
Name/Title: |
Raymond A. Myers |
| |
Date: |
10/22/2025 |
| |
Jason J. Martin |
| |
|
| |
Signature: |
/s/ Jason J. Martin |
| |
Name/Title: |
Jason J. Martin |
| |
Date: |
10/22/2025 |
Exhibit 2
Broadwood Partners Intends to Call Special Meeting
to Remove Several STAAR Surgical Directors
Cautions Board Against Taking Any Substantive
or Procedural Action on Alcon Transaction or
Delaying Shareholder Vote
Calls for Board Refresh to Rebuild Shareholder
Trust After Deeply Flawed Sales Process
NEW YORK--(BUSINESS
WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding
common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), notified the Company’s
Board of Directors (the “Board”) yesterday that it intends to call a Special Meeting of STAAR shareholders for the purpose
of removing several directors.
Neal C. Bradsher, Broadwood Founder and President, said:
“We informed the Board yesterday of our intention to
call a Special Meeting of shareholders for the purpose of removing several directors in light of the overwhelming opposition to the proposed
acquisition of STAAR by Alcon.
We once again caution the Board against taking any steps
to delay a vote on the proposed transaction or making any last-minute changes to the transaction without substantial input from and alignment
with shareholders.
It is clear to us that the Board no longer has the confidence
of shareholders, and that new directors are needed to properly steward the Company and restore shareholder trust.
We anticipate that a refreshed Board would consider, among
other matters, how to run a full, fair, independent, and open strategic alternatives process to maximize value that is untainted by the
process issues and conflicts of interest that afflicted this proposed transaction with Alcon.”
Broadwood encourages its fellow shareholders to review its materials
at www.LetSTAARShine.com and
to vote on the GREEN Proxy Card “AGAINST” the proposed acquisition of STAAR by Alcon
Inc.
About Broadwood
Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood
Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.
Certain Information Concerning the Participants
Special Meeting of Shareholders Scheduled for October 23, 2025
Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher,
Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”) are participants
in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders scheduled for October
23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special Meeting”). The Participants
have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GREEN Proxy
Card to be used in connection with any such solicitation of proxies from the Company’s shareholders for the Special Meeting. SHAREHOLDERS
OF STAAR ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE
PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) BECAUSE THEY CONTAIN OR
WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND ADDITIONAL INFORMATION RELATING
TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The Definitive Proxy Statement and
accompanying GREEN Proxy Card have been furnished to some or all of STAAR’s shareholders and will be, along with
other relevant documents, available at no charge on the SEC’s website at https://www.sec.gov/.
Special Meeting of Shareholders to Remove Members of the Board
The Participants also intend to file a definitive proxy statement and
an accompanying GREEN Proxy Card with the SEC to be used to solicit proxies with respect to removing members of the Board
and any other proposals that may come before a future and yet to be called or otherwise scheduled special meeting of shareholders (including
any adjournments, postponements, reschedulings or continuations thereof, the “Shareholder Meeting”). The Shareholder Meeting
will be separate, distinct and unrelated to the Special Meeting, and the Participants believe that the Shareholder Meeting will have no
effect on the outcome of the Special Meeting. The Participants do not believe that there is any lawful reason that would prevent or prohibit
the Participants from calling the Shareholder Meeting, regardless of the outcome of the shareholder vote at the Special Meeting, and do
not make any representation related to whether the Company may contest, or otherwise challenge, the Participants’ ability to call
the Shareholder Meeting. SHAREHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS
THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SHAREHOLDER MEETING AND ADDITIONAL INFORMATION RELATING TO THE
PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The definitive proxy statement and an accompanying GREEN Proxy
Card will be furnished to some or all of the Company’s shareholders and will be, along with other relevant documents, available
at no charge on the SEC’s website at https://www.sec.gov/.
Information about the Participants and a description of their direct
or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants with
the SEC on October 22, 2025 and is available here.
Contacts
Investor Contacts
John Ferguson / Joseph Mills
Saratoga Proxy Consulting LLC
jferguson@saratogaproxy.com
jmills@saratogaproxy.com
(212) 257-1311
(888) 368-0379
Media Contacts
Scott Deveau / Jeremy Jacobs
August Strategic Communications
Broadwood@AugustCo.com
(323) 892-5562
